Trial Profile
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy and Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Iroko Pharmaceuticals
- 23 Jun 2016 Results published in an Iroko Pharmaceuticals media release.
- 25 Aug 2014 Diclofenac [ZOROVOLEX] was approved by the US FDA for the management of osteoarthritis pain based on data from this trial and its extension study, according to an Iroko Pharmaceuticals media release.
- 29 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.